| Literature DB >> 31717980 |
Giorgia Montalbano1, Giorgia Borciani1,2, Carlotta Pontremoli1, Gabriela Ciapetti2, Monica Mattioli-Belmonte3, Sonia Fiorilli1, Chiara Vitale-Brovarone1.
Abstract
In the last years bone tissue engineering has been increasingly indicated as a valid solution to meet the challenging requirements for a healthy bone regeneration in case of bone loss or fracture. In such a context, bioactive glasses have already proved their great potential in promoting the regeneration of new bone tissue due to their high bioactivity. In addition, their composition and structure enable us to incorporate and subsequently release therapeutic ions such as strontium, enhancing the osteogenic properties of the material. The incorporation of these inorganic systems in polymeric matrices enables the formulation of composite systems suitable for the design of bone scaffolds or delivery platforms. Among the natural polymers, type I collagen represents the main organic phase of bone and thus is a good candidate to develop biomimetic bioactive systems for bone tissue regeneration. However, alongside the specific composition and structure, the key factor in the design of new biosystems is creating a suitable interaction with cells and the host tissue. In this scenario, the presented study aimed at combining nano-sized mesoporous bioactive glasses produced by means of a sol-gel route with type I collagen in order to develop a bioactive hybrid formulation suitable for bone tissue engineering applications. The designed system has been fully characterized in terms of physico-chemical and morphological analyses and the ability to release Sr2+ ions has been studied observing a more sustained profile in presence of the collagenous matrix. With the aim to improve the mechanical and thermal stability of the resulting hybrid system, a chemical crosslinking approach using 4-star poly (ethylene glycol) ether tetrasuccinimidyl glutarate (4-StarPEG) has been explored. The biocompatibility of both non-crosslinked and 4-StarPEG crosslinked systems was evaluated by in vitro tests with human osteoblast-like MG-63 cells. Collected results confirmed the high biocompatibility of composites, showing a good viability and adhesion of cells when cultured onto the biomaterial samples.Entities:
Keywords: 4-StarPEG; biomimetic composites; bone tissue engineering; collagen chemical crosslinking; mesoporous bioactive glasses; strontium release; type I collagen
Year: 2019 PMID: 31717980 PMCID: PMC6888293 DOI: 10.3390/ma12223719
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1N2 adsorption–desorption curves of MBG_Sr4%: (A) isotherms and (B) density functional theory (DFT) pore size distributions.
Figure 2Field-emission scanning electron microscopy (FESEM) images of MBG_Sr4% particles (A) and Coll/MBG_Sr4% samples (B,C); energy-dispersive X-ray spectroscopy (EDS) analyses showing the composition of MBG_Sr4% (D) and Coll/MBG_Sr4% system (E).
Figure 3Sr2+ ion release from MBG_Sr4% particles and the Coll/MBG_Sr4% system.
Figure 4Amplitude sweep test (A) and temperature ramp (B) performed on Coll/MBG_Sr4% samples.
Figure 5Weight loss of 4-StarPEG crosslinked and non-crosslinked Coll/MBG_Sr4% samples following incubation in collagenase up to 48 h.
Figure 6MG-63 cell viability on 4-StarPEG crosslinked and non-crosslinked samples at 24 and 72 h using the Alamar Blue assay.
Figure 7MG-63 cell viability indirect assay, using the conditioned medium (CM) diluted 1:1 (A) and 100:0, 50:50, 25:75 and 5:95 with fresh culture medium (B).
Figure 8SEM microphotographs of MG-63 adhesion on 4-StarPEG crosslinked Coll/MBG_Sr4% at 24 h (A) and 72 h (B,C), and non-crosslinked Coll/MBG_Sr4% after 24 h (D) and 72 h (E,F).